Viewing Study NCT03294694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-02-05 @ 12:56 AM
Study NCT ID: NCT03294694
Status: TERMINATED
Last Update Posted: 2025-05-31
First Post: 2017-09-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer View
None HER2-Negative Breast Cancer View
None Metastatic Epithelial Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer View
None HER2-Negative Breast Cancer View
None Metastatic Epithelial Ovarian Cancer View